
Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
MATIASGUIU, X; CAIXAS, A; COSTA, I; CABEZAS, R; PRAT, J
COMPOUND MEDULLaRY-PaPILLaRY CaRCINOMa OF THE THYROID - TRUE MIXED TUMOR
Histopathology 25 183-185. .
-
MATIASGUIU, X; CUATRECASAS, M; MUSULEN, E; PRAT, J
P53 EXPRESSION IN aNaPLaSTIC CaRCINOMaS aRISING FROM THYROID PaPILLaRY CaRCINOMaS
JOURNAL OF CLINICAL PATHOLOGY 47 337-339. .
-
KOMMINOTH, P; ROTH, J; SAREMASLANI, P; MATIASGUIU, X; WOLFE, HJ; HEITZ, PU
POLYSIaLIC aCID OF THE NEURaL CELL-aDHESION MOLECULE IN THE HUMaN THYROID - a MaRKER FOR MEDULLaRY-THYROID CaRCINOMa aND PRIMaRY C-CELL HYPERPLaSIa - aN IMMUNOHISTOCHEMICaL STUDY ON 79 THYROID LESIONS
AMERICAN JOURNAL OF SURGICAL PATHOLOGY 18 399-411. .
-
MATIASGUIU, X; PRAT, J; YOUNG, RH; CAPEN, CC; ROSOL, TJ; DELELLIS, RA; SCULLY, RE
HUMaN PaRaTHYROID-HORMONE RELaTED PROTEIN IN OVaRIaN SMaLL-CELL CaRCINOMa - aN IMMUNOHISTOCHEMICaL STUDY
CANCER 73 1878-1881. .
[doi:10.1002/1097-0142(19940401)73:7<1878::AID-CNCR2820730717>3.0.CO;2-D]
-
PRAT, J; CUATRECASAS, M; MATIASGUIU, X; VILLANUEVA, A; CAPELLA, G
K-RaS MUTaTIONS IN OVaRIaN MUCINOUS TUMORS
LABORATORY INVESTIGATION 70 94-94. .
-
MATIASGUIU, X; COLOMER, A; MARTINEZMAS, JV; PRAT, J; CARCIAAMEJEIRAS, A
ESTROGEN aND PROGESTERONE RECEPTORS IN MEDULLaRY-THYROID CaRCINOMa - a LIGaND-BINDING aND IMMUNOHISTOCHEMICaL STUDY
LABORATORY INVESTIGATION 70 54-54. .
-
MATIASGUIU, X; KOMMINOTH, P; PRAT, J
ABSENCE OF EPSTEIN-BaRR-VIRUS DNa IN LYMPHOEPITHELIOMa-LIKE CaRCINOMa OF THE UTERINE CERVIX
AMERICAN JOURNAL OF CLINICAL PATHOLOGY 101 117-117. .
-
ESPINOS, JJ; GARCIAPATOS, V; Guiu, XM; DELGADO, E
EaRLY SKIN METaSTaSIS OF ENDOMETRIaL aDENOCaRCINOMa - CaSE-REPORT aND REVIEW OF THE LITERaTURE
Cutis 52 109-111. .
-
ALEJO, M; MACEDO, I; MATIASGUIU, X; PRAT, J
ADENOCaRCINOMa IN-SITU OF THE UTERINE CERVIX - CLINICOPaTHOLOGICaL STUDY OF 9 CaSES WITH DETECTION OF HUMaN PaPILLOMaVIRUS DNa BY IN-SITU HYBRIDIZaTION aND POLYMERaSE CHaIN-REaCTION
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 12 219-223. .
-
SCHWARZSTEIN, D; GARCIAPATTERSON, A; GIMENEZ, G; CALAF, J; PUIGDOMINGO, M; CAIXAS, A; MATIASGUIU, X; WEBB, SM
DOPaMINERGIC RESISTaNCE IN a CaSE OF INVaSIVE MaCROPROLaCTINOMa
Journal Of Endocrinological Investigation 16 443-447. .
-
MIRALBELL, R; BALART, J; MATIASGUIU, X; MOLET, J; ARIZA, A; CRAVENBARTLE, J
RaDIOTHERaPY FOR SUPRaTENTORIaL LOW-GRaDE GLIOMaS - RESULTS aND PROGNOSTIC FaCTORS WITH SPECIaL FOCUS ON TUMOR VOLUME PaRaMETERS
RADIOTHERAPY AND ONCOLOGY 27 112-116. .
-
MARGALL, N; MATIASGUIU, X; CHILLON, M; COLL, P; ALEJO, M; NUNES, V; QUILEZ, M; RABELLA, N; PRATS, G; PRAT, J
DETECTION OF HUMaN PaPILLOMaVIRUS-16 aND PaPILLOMaVIRUS-18 DNa IN EPITHELIaL LESIONS OF THE LOWER GENITaL-TRaCT BY INSITU HYBRIDIZaTION aND POLYMERaSE CHaIN-REaCTION - CERVICaL SCRaPES aRE NOT SUBSTITUTES FOR BIOPSIES
JOURNAL OF CLINICAL MICROBIOLOGY 31 924-930. .
Projects
- Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU